2023 Q4 Form 10-Q Financial Statement

#000089353823000108 Filed on November 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $608.7M $640.9M
YoY Change -9.32% -23.29%
Cost Of Revenue $137.3M $138.3M
YoY Change -8.84% -13.54%
Gross Profit $471.4M $502.6M
YoY Change -9.46% -25.59%
Gross Profit Margin 77.44% 78.42%
Selling, General & Admin $36.64M $29.30M
YoY Change 11.56% 3.07%
% of Gross Profit 7.77% 5.83%
Research & Development $15.85M $10.20M
YoY Change 46.38% -28.18%
% of Gross Profit 3.36% 2.03%
Depreciation & Amortization $189.1M $189.4M
YoY Change 31.66% 29.85%
% of Gross Profit 40.11% 37.68%
Operating Expenses $242.0M $231.6M
YoY Change 28.6% 22.08%
Operating Profit $229.4M $195.6M
YoY Change -31.0% -68.57%
Interest Expense $62.64M $23.11M
YoY Change -646.13% 1.23%
% of Operating Profit 27.31% 11.81%
Other Income/Expense, Net -$232.0K -$233.0K
YoY Change -107.01% -120.03%
Pretax Income $291.8M $176.4M
YoY Change -9.75% -70.64%
Income Tax $44.70M -$45.98M
% Of Pretax Income 15.32% -26.07%
Net Earnings $247.1M $222.3M
YoY Change -4.39% -53.8%
Net Earnings / Revenue 40.59% 34.69%
Basic Earnings Per Share $1.89
Diluted Earnings Per Share $2.12 $1.88
COMMON SHARES
Basic Shares Outstanding 116.3M shares 118.7M shares
Diluted Shares Outstanding 118.3M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $616.2M $402.0M
YoY Change 38.46% -19.35%
Cash & Equivalents $616.2M $402.0M
Short-Term Investments
Other Short-Term Assets $69.11M $36.00M
YoY Change 17.32% -29.88%
Inventory
Prepaid Expenses
Receivables $231.2M $264.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $916.4M $702.6M
YoY Change 24.31% -13.03%
LONG-TERM ASSETS
Property, Plant & Equipment $5.376B $5.292B
YoY Change 10.11% 11.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.45M $78.43M
YoY Change 9.58% 28.93%
Total Long-Term Assets $5.464B $5.376B
YoY Change 9.74% 10.99%
TOTAL ASSETS
Total Short-Term Assets $916.4M $702.6M
Total Long-Term Assets $5.464B $5.376B
Total Assets $6.380B $6.079B
YoY Change 11.62% 7.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $107.3M $540.5M
YoY Change 144.46% -14.48%
Accrued Expenses $144.7M
YoY Change 15.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $633.8M $599.1M
YoY Change 5.89% -26.4%
LONG-TERM LIABILITIES
Long-Term Debt $1.575B $1.575B
YoY Change 0.2% 0.2%
Other Long-Term Liabilities $65.04M $56.33M
YoY Change -6.55% -23.57%
Total Long-Term Liabilities $2.130B $2.075B
YoY Change 4.84% 5.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $633.8M $599.1M
Total Long-Term Liabilities $2.130B $2.075B
Total Liabilities $2.764B $2.674B
YoY Change 5.08% -3.94%
SHAREHOLDERS EQUITY
Retained Earnings $2.052B $1.826B
YoY Change 56.84% 70.91%
Common Stock $1.566B $1.582B
YoY Change -12.06% -12.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.616B $3.404B
YoY Change
Total Liabilities & Shareholders Equity $6.380B $6.079B
YoY Change 11.62% 7.56%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $247.1M $222.3M
YoY Change -4.39% -53.8%
Depreciation, Depletion And Amortization $189.1M $189.4M
YoY Change 31.66% 29.85%
Cash From Operating Activities $476.5M $383.0M
YoY Change 65.23% -25.39%
INVESTING ACTIVITIES
Capital Expenditures $223.2M $237.2M
YoY Change -22.51% -204.91%
Acquisitions
YoY Change
Other Investing Activities -$43.00K $0.00
YoY Change -116.1% -100.0%
Cash From Investing Activities -$223.3M -$237.2M
YoY Change -22.42% 4.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -39.04M -122.1M
YoY Change -27.69% 120.69%
NET CHANGE
Cash From Operating Activities 476.5M 383.0M
Cash From Investing Activities -223.3M -237.2M
Cash From Financing Activities -39.04M -122.1M
Net Change In Cash 214.2M 23.70M
YoY Change -500.78% -89.76%
FREE CASH FLOW
Cash From Operating Activities $476.5M $383.0M
Capital Expenditures $223.2M $237.2M
Free Cash Flow $253.3M $145.8M
YoY Change 88141.11% -80.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
5294000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78430000 usd
CY2023Q3 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
83724000 usd
CY2023Q3 us-gaap Assets
Assets
6078570000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
540459000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
43152000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15473000 usd
CY2023Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1574553000 usd
CY2023Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
115271000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
324440000 usd
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4595000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56334000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2075193000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116313887 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1163000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1826002000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3982000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3404293000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6078570000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
639699000 usd
CY2022Q3 us-gaap Other Operating Income
OtherOperatingIncome
7893000 usd
CY2023Q3 us-gaap Revenues
Revenues
640901000 usd
CY2022Q3 us-gaap Revenues
Revenues
835451000 usd
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
138264000 usd
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
159961000 usd
CY2023Q3 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
189353000 usd
CY2022Q3 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
145865000 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
10245000 usd
CY2022Q3 us-gaap Exploration Expense
ExplorationExpense
14203000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29255000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28428000 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-75355000 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
137577000 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2832000 usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2290000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
445304000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
213170000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
599084000 usd
CY2023Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1581110000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
195597000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-67605000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1150000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1072440000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218951000 usd
us-gaap Net Income Loss
NetIncomeLoss
853489000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122318000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124233000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.87
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
us-gaap Net Income Loss
NetIncomeLoss
853489000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-546000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
546000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
854035000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3085458000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
198552000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18078000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4318000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
40468000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3229795000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
149874000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17704000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1816000 usd
CY2023Q2 sm Stock Issued During Period Value Restricted Stock Units And Performance Share Units
StockIssuedDuringPeriodValueRestrictedStockUnitsAndPerformanceShareUnits
-7000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3298467000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
222343000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17543000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
0 usd
CY2023Q3 sm Stock Issued During Period Value Restricted Stock Units And Performance Share Units
StockIssuedDuringPeriodValueRestrictedStockUnitsAndPerformanceShareUnits
-7875000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6038000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
97151000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2063131000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
48764000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
182000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1218000 usd
CY2022Q1 sm Stock Issued During Period Value Restricted Stock Units And Performance Share Units
StockIssuedDuringPeriodValueRestrictedStockUnitsAndPerformanceShareUnits
-24000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4274000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2115109000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
323485000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
182000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1645000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4479000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2444900000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
481240000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
182000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18419000 usd
CY2022Q3 sm Stock Issued During Period Value Restricted Stock Units And Performance Share Units
StockIssuedDuringPeriodValueRestrictedStockUnitsAndPerformanceShareUnits
-25105000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5105000 usd
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
20241000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2867662000 usd
us-gaap Net Income Loss
NetIncomeLoss
570769000 usd
us-gaap Net Income Loss
NetIncomeLoss
853489000 usd
us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
501374000 usd
us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
460169000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
14519000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13858000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-12352000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-385180000 usd
sm Cash Portion Of Gain Loss On Derivative Instrument
CashPortionOfGainLossOnDerivativeInstrument
20398000 usd
sm Cash Portion Of Gain Loss On Derivative Instrument
CashPortionOfGainLossOnDerivativeInstrument
-595080000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4114000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8910000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-67605000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43171000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
202996000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
11489000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14134000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
57329000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
13230000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1097879000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1398031000 usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
766756000 usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
591846000 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
109318000 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
7000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-657000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
589000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-875417000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-592442000 usd
us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
0 usd
us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
584946000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
205246000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20241000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1815000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1645000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
54167000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1218000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7882000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-35110000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-265480000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-639870000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43018000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
165719000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
444998000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
332716000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401980000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
498435000 usd
us-gaap Interest Paid Net
InterestPaidNet
77514000 usd
us-gaap Interest Paid Net
InterestPaidNet
125668000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-6176000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-10506000 usd
sm Increase Decrease In Capital Expenditure Accruals And Other
IncreaseDecreaseInCapitalExpenditureAccrualsAndOther
35683000 usd
sm Increase Decrease In Capital Expenditure Accruals And Other
IncreaseDecreaseInCapitalExpenditureAccrualsAndOther
50590000 usd
sm Noncash Financing Text
NoncashFinancingText
usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
639699000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
827558000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1757032000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2676656000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2022Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 usd
CY2022Q3 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2024-12-31
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2800000 shares
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2352000 shares
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
453000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
6316000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
453000 shares
CY2023Q3 sm Stock Repurchase Program Shares Repurchased Weighted Average Price Per Share
StockRepurchaseProgramSharesRepurchasedWeightedAveragePricePerShare
40.97
CY2022Q3 sm Stock Repurchase Program Shares Repurchased Weighted Average Price Per Share
StockRepurchaseProgramSharesRepurchasedWeightedAveragePricePerShare
44.69
sm Stock Repurchase Program Shares Repurchased Weighted Average Price Per Share
StockRepurchaseProgramSharesRepurchasedWeightedAveragePricePerShare
32.48
sm Stock Repurchase Program Shares Repurchased Weighted Average Price Per Share
StockRepurchaseProgramSharesRepurchasedWeightedAveragePricePerShare
44.69
CY2023Q3 sm Stock Repurchased And Retired During Period Excluding Taxes Commission And Fees Value
StockRepurchasedAndRetiredDuringPeriodExcludingTaxesCommissionAndFeesValue
96336000 usd
CY2022Q3 sm Stock Repurchased And Retired During Period Excluding Taxes Commission And Fees Value
StockRepurchasedAndRetiredDuringPeriodExcludingTaxesCommissionAndFeesValue
20232000 usd
sm Stock Repurchased And Retired During Period Excluding Taxes Commission And Fees Value
StockRepurchasedAndRetiredDuringPeriodExcludingTaxesCommissionAndFeesValue
205120000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
237700000 usd
CY2023Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3923000 usd
CY2022Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7014000 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6732000 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11287000 usd
CY2023Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1173000 usd
CY2022Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2317000 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1716000 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4668000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-51075000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
110048000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43171000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
202996000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-45979000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
119379000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51619000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218951000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.261
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.199
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.083
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.204
CY2023Q3 us-gaap Senior Notes
SeniorNotes
1574553000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
1572210000 usd
us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
The Company was in compliance with all financial and non-financial covenants as of September 30, 2023, and through the filing of this report.
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
4900000 usd
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
5100000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
16300000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
12300000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-16900000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
15800000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120165000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124233000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.98
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.88
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.75
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
30818000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
73142000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
47747000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
57323000 usd
CY2023Q3 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
26940000 usd
CY2022Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
26136000 usd
CY2023Q3 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
26940000 usd
CY2022Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
26136000 usd
CY2023Q3 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
3878000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
47006000 usd
CY2023Q3 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
20807000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
31187000 usd
CY2023Q3 sm Derivative Settlement Gain Or Loss
DerivativeSettlementGainOrLoss
314000 usd
CY2022Q3 sm Derivative Settlement Gain Or Loss
DerivativeSettlementGainOrLoss
186299000 usd
sm Derivative Settlement Gain Or Loss
DerivativeSettlementGainOrLoss
-20398000 usd
sm Derivative Settlement Gain Or Loss
DerivativeSettlementGainOrLoss
595080000 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-75355000 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
137577000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-12352000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-385180000 usd
CY2023Q3 sm Percentageof Proved Property Securedfor Credit Facility Borrowing
PercentageofProvedPropertySecuredforCreditFacilityBorrowing
0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.87
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
222343000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
481240000 usd
us-gaap Net Income Loss
NetIncomeLoss
570769000 usd
us-gaap Net Income Loss
NetIncomeLoss
853489000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117823000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123195000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119589000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122318000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
505000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1084000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
576000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1915000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118328000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124279000 shares
CY2023Q2 sm Net Acres Acquired
NetAcresAcquired
20000 acre
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
88900000 usd

Files In Submission

Name View Source Status
0000893538-23-000108-index-headers.html Edgar Link pending
0000893538-23-000108-index.html Edgar Link pending
0000893538-23-000108.txt Edgar Link pending
0000893538-23-000108-xbrl.zip Edgar Link pending
exhibit311certificationhvo.htm Edgar Link pending
exhibit312certificationwpu.htm Edgar Link pending
exhibit321906certification.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sm-20230930.htm Edgar Link pending
sm-20230930.xsd Edgar Link pending
sm-20230930_g1.jpg Edgar Link pending
sm-20230930_def.xml Edgar Link unprocessable
sm-20230930_cal.xml Edgar Link unprocessable
sm-20230930_lab.xml Edgar Link unprocessable
sm-20230930_pre.xml Edgar Link unprocessable
sm-20230930_htm.xml Edgar Link completed